Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC.

Jeffrey Sum Lung Wong,Gin Wai Kwok,Vikki Tang,Bryan Li,Roland Leung,Joanne Wing Yan Chiu,Ka Wing Ma,W.H. She,Wing Yan Josephine Tsang,Tan To Cheung,Thomas Yau

Nivolumab/pembrolizumab in Child-Pugh grade B/C patients with advanced HCC.

2021

Jeffrey Sum Lung Wong
Gin Wai Kwok
Vikki Tang
Bryan Li
Roland Leung
Joanne Wing Yan Chiu
Ka Wing Ma
W.H. She
Wing Yan Josephine Tsang
Tan To Cheung
Thomas Yau

e16184Background: Hepatic derangement commonly accompanies advanced HCC (aHCC) and limits the use of systemic therapies. We aimed to evaluate the use of single agent anti-PD-1 nivolumab or pembroli...

Keywords:

Child-Pugh - Grade
Medicine
single agent
Nivolumab
Oncology
Internal medicine
Pembrolizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations